Holen Sie sich die Stockscreener-App
4.20
4.11%
-0.18
Handel nachbörslich:
4.20
Orchestra Biomed Holdings Inc Aktie (OBIO) Neueste Nachrichten
Chardan reiterates Orchestra BioMed stock rating on trial focus By Investing.com - Investing.com Australia
Chardan reiterates Orchestra BioMed stock rating on trial focus - Investing.com UK
Orchestra BioMed Holdings, Inc. (OBIO) Exceeds Expectations for Q4 Earnings and Revenue - Bitget
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update - Investing News Network
Orchestra BioMed Holdings, Inc. (OBIO) Surpasses Q4 Earnings and Revenue Estimates - Yahoo Finance
Orchestra BioMed Holdings 10-K Summary — Revenue: $— | EPS: $— - TradingView
Aug Analyst Calls: Will Orchestra BioMed Holdings Inc benefit from AI trendsTrade Risk Summary & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Why Orchestra BioMed Holdings Inc. stock could outperform in 2026Portfolio Update Report & Risk Managed Trade Strategies - Naître et grandir
Insider Sell: How resilient is Orchestra BioMed Holdings Inc. stock in market downturns2025 Key Highlights & Verified Short-Term Trading Plans - Naître et grandir
Market Leaders: Does Orchestra BioMed Holdings Inc outperform in volatile markets2025 Buyback Activity & Stepwise Trade Execution Plans - baoquankhu1.vn
Orchestra BioMed to present hypertension therapy data at medical meetings By Investing.com - Investing.com Canada
Orchestra BioMed announces presentations highlighting Avim therapy potential impact on hypertensive heart disease and heart failure at THT and CRT - marketscreener.com
Orchestra BioMed to present hypertension therapy data at medical meetings - Investing.com
Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT - GlobeNewswire
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
OBIO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
RTW INVESTMENTS, LP Increases Stake in Orchestra BioMed Holdings Inc - GuruFocus
Medtronic (OBIO) affiliates hold 17.8% of Orchestra BioMed in amended 13G/A - Stock Titan
Earnings Beat: How much upside does Orchestra BioMed Holdings Inc have2025 Fundamental Recap & Accurate Technical Buy Alerts - baoquankhu1.vn
Orchestra BioMed to Present at Two Healthcare Conferences - MyChesCo
Gains Report: Is Tuya Inc Depositary Receipt a play on infrastructure spending - baoquankhu1.vn
OBIOOrchestra BioMed Holdings Inc Latest Stock News & Market Updates - Stock Titan
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Analysts Offer Insights on Healthcare Companies: Penumbra (PEN), Orchestra BioMed Holdings (OBIO) and Teladoc (TDOC) - The Globe and Mail
Will Orchestra BioMed Holdings Inc. benefit from geopolitical trendsJuly 2025 Decliners & Real-Time Volume Analysis Alerts - mfd.ru
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences - GlobeNewswire
Orchestra BioMed (NASDAQ:OBIO) Trading 4.2% HigherHere's What Happened - MarketBeat
Orchestra BioMed Grants Inducement Stock Options to Nine New Employees - MyChesCo
Earnings Recap: Will MITTPRA stock hit new highs in YEARQuarterly Earnings Report & Expert Approved Trade Ideas - baoquankhu1.vn
Orchestra BioMed announces inducement grants - Medical Buyer
What is Orchestra BioMed Holdings Inc. s P E ratio telling usJuly 2025 Drop Watch & Low Risk Profit Maximizing Plans - mfd.ru
Orchestra BioMed Adopts 2026 Performance-Driven Executive Compensation Plan - TipRanks
Orchestra BioMed Grants Stock Options to New Employees as Part of 2025 Inducement Plan - Quiver Quantitative
Does Orchestra BioMed Holdings Inc. outperform in volatile markets2025 Price Targets & Growth Focused Investment Plans - mfd.ru
Targets Report: How Orchestra BioMed Holdings Inc. stock performs after earningsJuly 2025 Outlook & AI Forecasted Stock Moves - mfd.ru
How sensitive is Orchestra BioMed Holdings Inc. to inflation2025 Trade Ideas & Fast Exit/Entry Strategy Plans - mfd.ru
MACD Signal: What is Orchestra BioMed Holdings Incs 5 year growth outlookEntry Point & Reliable Price Breakout Alerts - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Orchestra BioMed Holdings (OBIO), LENZ Therapeutics (LENZ) and Amgen (AMGN) - The Globe and Mail
Short Covering: Does Orchestra BioMed Holdings Inc outperform in volatile markets2025 Year in Review & Weekly Watchlist of Top Performers - baoquankhu1.vn
Guidance Update: Does Orchestra BioMed Holdings Inc stock benefit from AI growth2025 Winners & Losers & Long-Term Growth Portfolio Plans - baoquankhu1.vn
Risk Report: Is Rafael Holdings Inc affected by consumer sentimentShare Buyback & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) largest shareholders are retail investors with 41% ownership, institutions own 17% - Yahoo Finance
Aug Setups: What is Orchestra BioMed Holdings Inc. s 5 year growth outlookWeekly Trading Summary & Intraday High Probability Setup Alerts - baoquankhu1.vn
Orchestra BioMed Highlights AVIM Therapy’s Potential at CSI 2025 Meeting - MSN
AMH Equity Ltd Buys New Position in Orchestra BioMed Holdings, Inc. $OBIO - Defense World
Orchestra BioMed (NASDAQ:OBIO) versus Prima BioMed (NASDAQ:IMMP) Critical Analysis - Defense World
Retail Trends: Does PNTG have strong fundamentalsQuarterly Trade Summary & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Support Test: Is Orchestra BioMed Holdings Inc stock a contrarian buyQuarterly Performance Summary & Safe Entry Momentum Stock Tips - Bộ Nội Vụ
Retail Trends: Should value investors consider Orchestra BioMed Holdings Inc - baoquankhu1.vn
symbol__ Stock Quote Price and Forecast - CNN
Haemonetics (HAE) Acquisition of Vivasure Boosts Orchestra BioMed's Finances - GuruFocus
Orchestra BioMed Holdings, Inc. to Receive Proceeds from Vivasure Acquisition - TradingView
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):